Novartis Just Surged 7%-Plus, Flying By A Flat-Base Buy Point

Novartis stock surged early Tuesday after its experimental multiple sclerosis treatment succeeded in a pair of midstage studies. The post Novartis Just Surged 7%-Plus, Flying By A Flat-Base Buy Point appeared first on Investor's Business Daily.